NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Clinical trial NCT06622668 · WITHDRAWN

Trial details

NCT number: NCT06622668
Sponsor: Intellia Therapeutics
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Disease Pulmonary Disease AATD Alpha-1 Antitrypsin Deficiency Alpha-1 Antitrypsin Deficiency-associated Lung Disease

Start date: 2024-11-20
Primary completion: 2025-01-09
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.